Global Epinephrine Autoinjector Market 2024-2028

PUBLISHED: November 24, 2023

PAGES: 154 Pages

DELIVERY TIME: 1-2 business days

SELECT AN OPTION

The epinephrine autoinjector market is forecasted to grow by USD 2.44 bn during 2023-2028, accelerating at a CAGR of 10.59% during the forecast period. The report on the epinephrine autoinjector market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, rising innovations in marketing strategies by vendors, and rise in awareness of anaphylaxis and availability of innovative epinephrine autoinjectors.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	8.78%
CAGR	10.59%
Incremental Value	$2.44bn

Technavio's epinephrine autoinjector market is segmented as below:

By Type

0.30gm
0.15gm
0.50gm

By End-user

Hospitals
clinics
Homecare

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the frequent product launches due to government pressure on vendors as one of the prime reasons driving the epinephrine autoinjector market growth during the next few years. Also, growing awareness about epinephrine autoinjectors and increase in patient assistance programs offered by different vendors and other organizations will lead to sizable demand in the market.

The report on the epinephrine autoinjector market covers the following areas:

Epinephrine autoinjector market sizing
Epinephrine autoinjector market forecast
Epinephrine autoinjector market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading epinephrine autoinjector market vendors that include Adamis Pharmaceuticals Corp., ALK Abello AS, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., BIOPROJET, Crossject, Halozyme Therapeutics Inc., kaleo Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the epinephrine autoinjector market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43297

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global epinephrine autoinjector market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global epinephrine autoinjector market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 0.30gm - Market size and forecast 2023-2028
Exhibit 34: Chart on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on 0.30gm - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on 0.30gm - Year-over-year growth 2023-2028 (%)
6.4 0.15gm - Market size and forecast 2023-2028
Exhibit 38: Chart on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on 0.15gm - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on 0.15gm - Year-over-year growth 2023-2028 (%)
6.5 0.50gm - Market size and forecast 2023-2028
Exhibit 42: Chart on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on 0.50gm - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on 0.50gm - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ billion)
Exhibit 47: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Homecare - Market size and forecast 2023-2028
Exhibit 56: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Homecare - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Adamis Pharmaceuticals Corp.
Exhibit 111: Adamis Pharmaceuticals Corp. - Overview
Exhibit 112: Adamis Pharmaceuticals Corp. - Business segments
Exhibit 113: Adamis Pharmaceuticals Corp. - Key offerings
Exhibit 114: Adamis Pharmaceuticals Corp. - Segment focus
12.4 ALK Abello AS
Exhibit 115: ALK Abello AS - Overview
Exhibit 116: ALK Abello AS - Product / Service
Exhibit 117: ALK Abello AS - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Exhibit 118: Amneal Pharmaceuticals Inc. - Overview
Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 120: Amneal Pharmaceuticals Inc. - Key news
Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus
12.6 Bausch Health Companies Inc.
Exhibit 123: Bausch Health Companies Inc. - Overview
Exhibit 124: Bausch Health Companies Inc. - Business segments
Exhibit 125: Bausch Health Companies Inc. - Key news
Exhibit 126: Bausch Health Companies Inc. - Key offerings
Exhibit 127: Bausch Health Companies Inc. - Segment focus
12.7 BIOPROJET
Exhibit 128: BIOPROJET - Overview
Exhibit 129: BIOPROJET - Product / Service
Exhibit 130: BIOPROJET - Key offerings
12.8 Crossject
Exhibit 131: Crossject - Overview
Exhibit 132: Crossject - Product / Service
Exhibit 133: Crossject - Key offerings
12.9 Halozyme Therapeutics Inc.
Exhibit 134: Halozyme Therapeutics Inc. - Overview
Exhibit 135: Halozyme Therapeutics Inc. - Product / Service
Exhibit 136: Halozyme Therapeutics Inc. - Key offerings
12.10 kaleo Inc.
Exhibit 137: kaleo Inc. - Overview
Exhibit 138: kaleo Inc. - Product / Service
Exhibit 139: kaleo Inc. - Key offerings
12.11 Pfizer Inc.
Exhibit 140: Pfizer Inc. - Overview
Exhibit 141: Pfizer Inc. - Product / Service
Exhibit 142: Pfizer Inc. - Key news
Exhibit 143: Pfizer Inc. - Key offerings
12.12 Teva Pharmaceutical Industries Ltd.
Exhibit 144: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 145: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 146: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 147: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 148: Teva Pharmaceutical Industries Ltd. - Segment focus
12.13 Viatris Inc.
Exhibit 149: Viatris Inc. - Overview
Exhibit 150: Viatris Inc. - Business segments
Exhibit 151: Viatris Inc. - Key news
Exhibit 152: Viatris Inc. - Key offerings
Exhibit 153: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 154: Inclusions checklist
Exhibit 155: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 156: Currency conversion rates for US$
13.4 Research methodology
Exhibit 157: Research methodology
Exhibit 158: Validation techniques employed for market sizing
Exhibit 159: Information sources
13.5 List of abbreviations
Exhibit 160: List of abbreviations

Product Code: IRTNTR43297

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global epinephrine autoinjector market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on 0.30gm - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on 0.30gm - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on 0.30gm - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on 0.15gm - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on 0.15gm - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on 0.15gm - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on 0.50gm - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on 0.50gm - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on 0.50gm - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ billion)
Exhibits47: Data Table on Market opportunity by Type ($ billion)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Homecare - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Homecare - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Adamis Pharmaceuticals Corp. - Overview
Exhibits112: Adamis Pharmaceuticals Corp. - Business segments
Exhibits113: Adamis Pharmaceuticals Corp. - Key offerings
Exhibits114: Adamis Pharmaceuticals Corp. - Segment focus
Exhibits115: ALK Abello AS - Overview
Exhibits116: ALK Abello AS - Product / Service
Exhibits117: ALK Abello AS - Key offerings
Exhibits118: Amneal Pharmaceuticals Inc. - Overview
Exhibits119: Amneal Pharmaceuticals Inc. - Business segments
Exhibits120: Amneal Pharmaceuticals Inc. - Key news
Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits123: Bausch Health Companies Inc. - Overview
Exhibits124: Bausch Health Companies Inc. - Business segments
Exhibits125: Bausch Health Companies Inc. - Key news
Exhibits126: Bausch Health Companies Inc. - Key offerings
Exhibits127: Bausch Health Companies Inc. - Segment focus
Exhibits128: BIOPROJET - Overview
Exhibits129: BIOPROJET - Product / Service
Exhibits130: BIOPROJET - Key offerings
Exhibits131: Crossject - Overview
Exhibits132: Crossject - Product / Service
Exhibits133: Crossject - Key offerings
Exhibits134: Halozyme Therapeutics Inc. - Overview
Exhibits135: Halozyme Therapeutics Inc. - Product / Service
Exhibits136: Halozyme Therapeutics Inc. - Key offerings
Exhibits137: kaleo Inc. - Overview
Exhibits138: kaleo Inc. - Product / Service
Exhibits139: kaleo Inc. - Key offerings
Exhibits140: Pfizer Inc. - Overview
Exhibits141: Pfizer Inc. - Product / Service
Exhibits142: Pfizer Inc. - Key news
Exhibits143: Pfizer Inc. - Key offerings
Exhibits144: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits145: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits146: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits147: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits148: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits149: Viatris Inc. - Overview
Exhibits150: Viatris Inc. - Business segments
Exhibits151: Viatris Inc. - Key news
Exhibits152: Viatris Inc. - Key offerings
Exhibits153: Viatris Inc. - Segment focus
Exhibits154: Inclusions checklist
Exhibits155: Exclusions checklist
Exhibits156: Currency conversion rates for US$
Exhibits157: Research methodology
Exhibits158: Validation techniques employed for market sizing
Exhibits159: Information sources
Exhibits160: List of abbreviations